targeted-therapy

Documents about targeted-therapy

• The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway#277879Scholar Commons
• CFTR modulator response in nasal organoids derived from people with cystic fibrosis#288364IRIS
• ETIOPATHOGENESIS, MODERN DIAGNOSTICS, AND TREATMENT METHODS OF ABNORMAL UTERINE BLEEDING#299525Zenodo (CERN)
• The potential of targeted IL-4 therapy for the comorbidity of atopic dermatitis and attention-deficit/hyperactivity disorder in children via the skin-brain axis.#402458NCBI PubMed Central
• The dual role of leukotrienes in the tumor microenvironment: balancing pro-tumorigenic and anti-tumor immunity#478505Europe PMC
• m1A and m6A RNA Methylations as Druggable Targets in Cancer#656626İzmir Yüksek Teknoloji Enstitüsü
• Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC#842304ClinicalTrials.gov
• To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC#860011ClinicalTrials.gov
• Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases#868988ClinicalTrials.gov
• Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System#916420ClinicalTrials.gov
• Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology#161134Zenodo (CERN)
• ¹⁸F-PSMA-1007 PET-CT-Directed Focal Therapy for MRI-Invisible Prostate Cancer#879002ClinicalTrials.gov
• A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing#904232ClinicalTrials.gov
• Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection#249586ClinicalTrials.gov
• The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma#268874IRIS
• Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors#277899Scholar Commons
• Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial#442100ClinicalTrials.gov
• Next generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies#655218ULRR
• Wireless Nerve Stimulation Device To Enhance Recovery After Stroke#839105ClinicalTrials.gov
• On-treatment Biomarkers in Metastatic Colorectal Cancer for Life#839303ClinicalTrials.gov
• CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.#1045759ClinicalTrials.gov
• Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects#1048067ClinicalTrials.gov
• T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia#851126ClinicalTrials.gov
• A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations#968806ClinicalTrials.gov
• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Covalently Anti-HER2-Functionalized MOF for Targeted Chemotherapy and NIR-Activated Photothermal/Photodynamic Cancer Therapy#279867Figshare
• Cascade Therapy With Doxorubicin and Survivin-Targeted Tailored Nanoparticles: an Effective Alternative for Sensitization of Cancer Cells To Chemotherapy#681779İzmir Yüksek Teknoloji Enstitüsü
• T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.#802603ClinicalTrials.gov
• Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia#967338ClinicalTrials.gov
• Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.#232228NCBI PubMed Central
• Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx#300638Figshare
• Precision Oncology: Targeting Genomic Alterations and Cancer Signaling with Integrative Multi-Omics, Deep Learning and Network Biology in Medical Oncology#406809OSF
• Survival outcomes of intensity-modulated radiotherapy combined with immunotherapy and targeted therapy for hepatocellular carcinoma with classification I-IV portal vein tumor thrombus: a propensity score matching study.#449939NCBI PubMed Central
• Design and evaluation of a novel peptide-EV complex for targeted Alzheimer’s disease therapy#478479Figshare
• Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody#849116ClinicalTrials.gov
• Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma#853405ClinicalTrials.gov
• The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer#862884ClinicalTrials.gov
• Chronic Myeloid Leukemia (CML) Real-Life Database#893218ClinicalTrials.gov
• The Drug Rediscovery Protocol (DRUP Trial)#894253ClinicalTrials.gov
• Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)#839229ClinicalTrials.gov
• A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors#875665ClinicalTrials.gov
• Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer#870227ClinicalTrials.gov
• Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives#120190Europe PMC
• Expert opinion on targeted lipid control for very-high-risk Indian patients: bridging the gap in real-world practice#336484Spiral
• A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors#832218ClinicalTrials.gov
• Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML#886957ClinicalTrials.gov
• Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study#907300ClinicalTrials.gov
• Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.#903937ClinicalTrials.gov
• C/EBP-β-regulated complement hyperactivation in spleen of SFTSV-infected mice: A clue to targeted complement therapy#13952PLOS
• A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma#158195ClinicalTrials.gov